SCHEMBL4402097

SCHEMBL4402097

NC(=O)c1ccc(NC(=O)ON2C(=O)CCC2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.49
ALDH1A1 P00352 3/20 0.49
MAPK1 P28482 1/20 0.49
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
HPGD P15428 2/20 0.42
POLB P06746 2/20 0.40
KMT2A Q03164 4/20 0.40
MAPT P10636 2/20 0.40
BCAT2 O15382 1/20 0.40
TYK2 P29597 1/20 0.40
CYP2C9 P11712 1/20 0.40
MEN1 O00255 2/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22295270 0.92 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1MAPK1NPC1RAB9A
SCHEMBL19386385 0.90 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1MAPK1NPC1RAB9A
SCHEMBL22755094 0.88 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1MAPK1NPC1RAB9A
SCHEMBL4401957 0.86 CA12 (0.47) ALDH1A1RAB9AHPGDPOLBKMT2A
SCHEMBL9086106 0.83 GAA (0.44) SMN1; SMN2ALDH1A1MAPK1NPC1RAB9A
SCHEMBL14960465 0.82 HPGD (0.43) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD
SCHEMBL4399509 0.81 NPC1 (0.54) SMN1; SMN2ALDH1A1NPC1RAB9APOLB
SCHEMBL4403971 0.81 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1NPC1L3MBTL1HPGD
SCHEMBL1205198 0.81 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1NPC1RAB9AKMT2A
SCHEMBL27807368 0.79 PARP10 (0.42) ALDH1A1L3MBTL1HPGDPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4033223-B1 METHODS FOR THE RAPID PREPARATION OF LABELED GLYCOSYLAMINES AND FOR THE ANALYSIS OF GLYCOSYLATED BIOMOLECULES PRODUCING THE SAME WATERS TECHNOLOGIES CORP (US) 2025-06-18 EP disclosed
US-12158472-B2 Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same WATERS TECHNOLOGIES CORPORATION (US) 2024-12-03 US disclosed
US-11747310-B2 Methods for liquid chromatography calibration for rapid labeled N-glycans WATERS TECHNOLOGIES CORPORATION (US) 2023-09-05 US disclosed
US-11747310-B2 Methods for liquid chromatography calibration for rapid labeled N-glycans WATERS TECHNOLOGIES CORPORATION (US) 2023-09-05 US disclosed
US-11747310-B2 Methods for liquid chromatography calibration for rapid labeled N-glycans WATERS TECHNOLOGIES CORPORATION (US) 2023-09-05 US disclosed
EP-3744708-B1 CALIBRANT FOR LIQUID CHROMATOGRAPHY CALIBRATION OF LABELED N-GLYCANS WATERS TECHNOLOGIES CORP (US) 2023-08-09 EP disclosed
US-20220268779-A1 METHODS FOR THE RAPID PREPARATION OF LABELED GLYCOSYLAMINES AND FOR THE ANALYSIS OF GLYCOSYLATED BIOMOLECULES PRODUCING THE SAME WATERS TECHNOLOGIES CORPORATION (US) 2022-08-25 US disclosed
EP-4033223-A1 METHODS FOR THE RAPID PREPARATION OF LABELED GLYCOSYLAMINES AND FOR THE ANALYSIS OF GLYCOSYLATED BIOMOLECULES PRODUCING THE SAME Waters Technologies Corporation (US) 2022-07-27 EP disclosed
US-11371996-B2 Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same WATERS TECHNOLOGIES CORPORATION (US) 2022-06-28 US disclosed
US-11371996-B2 Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same WATERS TECHNOLOGIES CORPORATION (US) 2022-06-28 US disclosed
US-8445292-B2 Compounds and methods for rapid labeling of N-glycans PROZYME, INC. (US) 2013-05-21 US disclosed
US-20120107942-A1 COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS PROZYME, INC. (US) 2012-05-03 US disclosed
US-8124792-B2 Compounds and methods for rapid labeling of N-glycans PROZYME, INC. (US) 2012-02-28 US disclosed
US-20090258437-A1 COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS PROZYME, INC. (US) 2009-10-15 US disclosed
WO-2009100155-A1 COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS PROZYME, INC. (US) 2009-08-13 WO disclosed
US-6218379-B1 Tricyclic carbacephems HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-0912574-A1 BETA-LACTAMS F. HOFFMANN-LA ROCHE AG (CH) 1999-05-06 EP disclosed
WO-1997045429-A1 BETA-LACTAMS F. HOFFMANN-LA ROCHE AG (CH) 1997-12-04 WO disclosed
US-5494666-A BETA-LACTAMASE INHIBITORS, ANTIBACTERIALS HOFFMANN-LA ROCHE INC. (US) 1996-02-27 US disclosed
US-5464617-A 1H-2,6a-diazacyclobut(cd)indene-6-carboxylic acid derivatives, antibiotics HOFFMANN-LA ROCHE INC. (US) 1995-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11747310-B2 Methods for liquid chromatography calibration for rapid labeled N-glycans DDOST, STT3B, CSGALNACT1 SMN1; SMN2 4368/4885ALDH1A1 1045/4885MAPK1 1215/4885
US-20090258437-A1 COMPOUNDS AND METHODS FOR RAPID LABELING OF N-GLYCANS B3GNT2, FUT5, FUT6 SMN1; SMN2 4712/4885ALDH1A1 2931/4885MAPK1 3983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.